Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

9.8%

4 terminated out of 41 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

12%

5 trials in Phase 3/4

Results Transparency

6%

1 of 16 completed with results

Key Signals

1 with results80% success

Data Visualizations

Phase Distribution

26Total
Not Applicable (16)
Early P 1 (1)
P 1 (1)
P 2 (3)
P 3 (2)
P 4 (3)

Trial Status

Completed16
Unknown8
Not Yet Recruiting6
Recruiting6
Terminated4
Withdrawn1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (41)

Showing 20 of 20 trials
NCT05646485Not ApplicableRecruiting

Bladder Cancer Screening Trial

NCT04943380CompletedPrimary

Efficacy and Utility of Cxbladder Tests in Hematuria Patients

NCT06948331Phase 2Not Yet RecruitingPrimary

RADA16 for Aquablation Day Case

NCT07431931Not ApplicableNot Yet Recruiting

Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria

NCT07395037Recruiting

A Study of Ward Admissions for Haematuria

NCT06818136RecruitingPrimary

Bladder EpiCheck European Haematuria Study

NCT07307300Not Yet RecruitingPrimary

Study on Risk Assessment for Patients With Microscopic Hematuria (Non-Visible Blood in Urine) Using a Urine Marker Test

NCT02276924Not ApplicableCompletedPrimary

Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors

NCT07037589RecruitingPrimary

Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed?

NCT01563796TerminatedPrimary

Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer

NCT03988309Not ApplicableCompletedPrimary

STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA

NCT06504771Not Yet RecruitingPrimary

Clinical and Laboratory Patterns of Pediatric Gross Hematuria

NCT06469229Not Yet RecruitingPrimary

Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria

NCT06427993Not Yet RecruitingPrimary

Urine DNA Methylation Detection for Hematuria Evaluation

NCT05620784Phase 3Recruiting

Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP

NCT06026189Not ApplicableRecruitingPrimary

Safely Reduce Cystoscopic Evaluations for Hematuria Patients

NCT04971057Not ApplicableCompleted

Multimedia Information for Patients With Renal Biopsy

NCT05314582CompletedPrimary

Anticoagulant/Antiaggregant Use and Postoperative Bleeding Risk in Patients With Bladder Tumor and Benign Prostatic Hyperplasia

NCT05893316UnknownPrimary

UroCAD for Hematuria Evaluation--A Prospective, Multi-center Study

NCT05415865Phase 3Unknown

The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder

Scroll to load more

Research Network

Activity Timeline